ECE1 Antibody

What is ECE1 and what is its significance in physiological processes?

ECE1 (Endothelin Converting Enzyme 1) is a membrane-bound metalloprotease responsible for converting big endothelin to active endothelin, a potent vasoconstrictor peptide. The canonical human ECE1 protein consists of 770 amino acid residues with a molecular mass of approximately 87.2 kDa . It plays crucial roles in GPCR signaling pathways and cardiac tissue development . ECE1 is particularly important in cardiovascular research due to its implications in the development of hypertension and heart failure . The enzyme has also been associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction .

ECE1 is primarily localized in the cell membrane as a single-pass type II membrane protein . Up to four different isoforms have been reported, and it's widely expressed across numerous tissue types . As a member of the Peptidase M13 protein family, ECE1 has orthologs in multiple species including mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken .

What is the molecular weight range observed for ECE1 in experimental applications?

While the calculated molecular weight of ECE1 is 87.2 kDa based on its amino acid sequence , researchers should note that the observed molecular weight in experimental applications typically ranges from 125-135 kDa . This discrepancy between calculated and observed molecular weights is important to consider when interpreting Western blot results and may be attributed to post-translational modifications such as glycosylation.

What criteria should be considered when selecting an ECE1 antibody for research applications?

When selecting an ECE1 antibody for research, consider the following critical factors:

• Specificity and cross-reactivity: Verify species reactivity based on your experimental model. For example, some antibodies like the ECE-1 Antibody (303913) are specific to human samples , while others such as ECE1 Polyclonal Antibody (CAB21824) show reactivity with human, mouse, and rat samples .

• Antibody format: Consider whether monoclonal (e.g., Rat IgG clone #303913 ) or polyclonal (e.g., Rabbit polyclonal antibodies ) is more appropriate for your application.

• Validated applications: Ensure the antibody has been validated for your specific application. Common applications for ECE1 antibodies include Western blot, immunohistochemistry, ELISA, and flow cytometry .

• Immunogen information: Review the immunogen used to generate the antibody. For instance, some are developed against recombinant fusion proteins containing specific amino acid sequences of human ECE1 (e.g., amino acids 670-770 or Gln90-Trp770 ).

• Performance in positive controls: Check whether the antibody has been tested in relevant cell lines or tissues, such as HeLa cells, A549 cells, or human breast cancer tissue .

How should ECE1 antibodies be validated before experimental use?

A comprehensive validation approach for ECE1 antibodies should include:

• Western blot analysis: Validate using positive controls such as HeLa or A549 cells . Expect bands at 125-135 kDa rather than the calculated 87.2 kDa .

• Immunohistochemistry controls: For IHC applications, use known positive tissues such as human breast cancer samples with appropriate antigen retrieval methods (TE buffer pH 9.0 or citrate buffer pH 6.0) .

• Specificity testing: Perform ELISA tests to confirm specific binding to ECE1 .

• Dilution optimization: Test recommended dilution ranges (e.g., 1:500-1:2000 for WB, 1:50-1:500 for IHC) to determine optimal conditions for your specific samples .

• Knockdown/knockout validation: Where possible, include ECE1 knockdown or knockout samples as negative controls to confirm antibody specificity .

What are the optimal conditions for using ECE1 antibodies in Western blot applications?

For optimal Western blot results with ECE1 antibodies:

• Sample preparation: Use cell lines with confirmed ECE1 expression such as HeLa or A549 cells .

• Loading control: Include appropriate loading controls and protein ladder to accurately assess the 125-135 kDa band corresponding to ECE1 .

• Antibody dilution: Start with manufacturer-recommended dilutions, typically in the range of 1:500-1:2000 , and optimize based on signal-to-noise ratio.

• Incubation conditions: Follow specific protocols provided by manufacturers. For example, the ECE1 antibody 26088-1-AP has a specific Western blot protocol available .

• Detection method: Use appropriate secondary antibodies compatible with your primary antibody host species (rabbit or rat) and visualization system.

• Recognition of multiple isoforms: Be aware that up to four different isoforms of ECE1 have been reported , which may appear as multiple bands on your blot.

How can ECE1 antibodies be effectively utilized in immunohistochemistry?

For successful immunohistochemistry with ECE1 antibodies:

• Tissue preparation: Use appropriate fixation methods compatible with your antibody of choice.

• Antigen retrieval: Follow specific recommendations, such as using TE buffer pH 9.0 or alternatively citrate buffer pH 6.0 for the 26088-1-AP antibody .

• Antibody dilution: Begin with recommended dilutions, generally 1:50-1:500 for IHC applications , and optimize as needed.

• Incubation conditions: Follow manufacturer protocols for incubation time and temperature.

• Positive controls: Include tissues known to express ECE1, such as human breast cancer tissue .

• Visualization: Use appropriate detection systems compatible with your primary antibody.

• Counterstaining: Include appropriate nuclear and/or cytoplasmic counterstaining to facilitate interpretation of membrane localization of ECE1.

How can ECE1 antibodies be used to study protein-protein interactions, particularly with tetraspanins?

Recent research has identified significant interactions between ECE1 and tetraspanins, particularly Tspan8. To investigate these interactions:

• Co-immunoprecipitation: ECE1 can be detected in both CD9 and Tspan8 immunoprecipitates collected from Brij97 lysates of Tspan8-expressing cells, but not in immunoprecipitates of control cells . This approach can be used to study ECE1's association with other membrane proteins.

• Protein complex analysis: Mass spectrometry analysis reveals that ECE1 associates with tetraspanin-enriched microdomains, as indicated in Table 1 from the referenced study :

• Cell surface biotinylation: To demonstrate that the association between ECE1 and proteins like Tspan8 occurs at the cell surface, biotinylate cell surface proteins before lysis using mild detergents (e.g., Brij97) to preserve protein-protein interactions .

• Functional enzymatic assays: Investigate how these interactions affect ECE1 enzymatic activity by measuring the conversion of bigET1 to ET1 in the presence or absence of specific interaction partners .

What methods can be used to study ECE1 enzymatic activity in different experimental models?

To investigate ECE1 enzymatic activity:

• Intestinal tissue preparation: Use intestinal pieces (e.g., from ileum) from experimental and control animals. Wash tissues in cold PBS, slice longitudinally, and rinse thoroughly before culture .

• Enzymatic activity assay: Add substrate (e.g., 100 ng/mL of bigET1) to the culture medium and measure the conversion to ET1 using ELISA. Compare results to vehicle controls to distinguish between conversion of exogenous bigET1 and endogenous production of ET1 .

• Normalization: Normalize the amount of converted ET1 by DNA content of the tissue samples. Extract DNA from tissue pieces using appropriate kits and measure concentration using fluorometric methods .

• Statistical analysis: Apply appropriate statistical tests such as Wilcoxon matched pairs rank test for paired samples or 2-way ANOVA for comparing antibody effects on bigET1 conversion .

• Antibody inhibition studies: Investigate how specific antibodies against ECE1 or its interaction partners affect enzymatic activity to elucidate regulatory mechanisms .

What are common challenges when working with ECE1 antibodies and how can they be addressed?

Researchers may encounter several challenges when working with ECE1 antibodies:

How should ECE1 antibodies be stored and handled to maintain optimal performance?

For optimal performance and longevity of ECE1 antibodies:

• Storage temperature: Follow manufacturer recommendations, typically storing at -20°C for long-term storage or 4°C for certain conjugated antibodies (e.g., biotin-conjugated antibodies should be stored at 4°C in the dark) .

• Buffer composition: ECE1 antibodies are typically stored in PBS with preservatives such as 0.02% sodium azide and stabilizers like 50% glycerol (pH 7.3) .

• Aliquoting: For smaller sized antibody preparations (e.g., 20μL), aliquoting may be unnecessary for -20°C storage . For larger volumes, consider creating single-use aliquots to avoid repeated freeze-thaw cycles.

• Stability: Most antibodies are stable for one year after shipment when stored properly .

• Working dilutions: Prepare working dilutions immediately before use rather than storing diluted antibody for extended periods.

• Handling precautions: Avoid repeated freeze-thaw cycles, exposure to light (especially for conjugated antibodies), and contamination.

How are ECE1 antibodies utilized in cardiovascular and hypertension research?

ECE1 antibodies are valuable tools in cardiovascular research due to the enzyme's role in converting big endothelin to active endothelin, a potent vasoconstrictor involved in hypertension and heart failure . Research applications include:

• Expression analysis: Use Western blot and IHC to quantify and localize ECE1 expression in normal versus diseased cardiovascular tissues .

• Regulatory mechanisms: Investigate how ECE1 expression and activity are regulated under different pathophysiological conditions.

• Therapeutic target validation: Evaluate ECE1 as a potential therapeutic target by studying how modulation of its expression or activity affects disease progression.

• Biomarker studies: Assess whether ECE1 levels correlate with disease severity or treatment response in cardiovascular disorders.

• Drug development: Screen for compounds that modulate ECE1 activity and evaluate their effects on endothelin production and cardiovascular parameters.

What is the relevance of ECE1 in Hirschsprung disease research and how are antibodies applied in this context?

ECE1 has been associated with Hirschsprung disease, a condition characterized by absence of enteric ganglia in distal colon causing functional intestinal obstruction . Research applications include:

• Genetic and functional studies: Investigate ECE1 gene variants in patients with Hirschsprung disease and characterize their functional consequences using ECE1 antibodies.

• Tissue expression analysis: Compare ECE1 expression patterns in normal and affected intestinal tissues using immunohistochemistry.

• Mechanistic investigations: Study the relationship between ECE1, endothelin signaling, and neural crest cell development in the context of enteric nervous system formation.

• Animal models: Use ECE1 antibodies to characterize expression patterns in animal models of Hirschsprung disease, such as knockout or transgenic mice.

• Protein interaction studies: Investigate ECE1 interactions with other proteins implicated in Hirschsprung disease pathogenesis, using co-immunoprecipitation and other protein-protein interaction methods.